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Elisabeth C McLemore, MD, FACS, David A Margolin, MD, FACS, Danny A Sherwinter, MD, FACS,
Sang W Lee, MD, FACS, Anthony J Senagore, MD, FACS, Michael J Phelan, PhD,
Michael J Stamos, MD, FACSBACKGROUND: Our primary objective was to demonstrate the utility and feasibility of the intraoperative
assessment of colon and rectal perfusion using fluorescence angiography (FA) during left-
sided colectomy and anterior resection. Anastomotic leak (AL) after colorectal resection
increases morbidity, mortality, and, in cancer cases, recurrence rates. Inadequate perfusion
may contribute to AL. The PINPOINT Endoscopic Fluorescence Imaging System allows for
intraoperative assessment of anastomotic perfusion.
STUDY DESIGN: This is a prospective, multicenter, open-label, clinical trial that assessed the feasibility and
utility of FA for intraoperative perfusion assessment during left-sided colectomy and anterior
resection at 11 centers in the United States.
RESULTS: A total of 147 patients were enrolled, of whom 139 were eligible for analysis. Diverticulitis
(44%), rectal cancer (25%), and colon cancer (21%) were the most prevalent indications for
surgery. The mean level of anastomosis was 10  4 cm from the anal verge. Splenic-flexure
mobilization was performed in 81% and high ligation of the inferior mesenteric artery in
61.9% of patients. There was a 99% success rate for FA, and FA changed surgical plans in 11
(8%) patients, with the majority of changes occurring at the time of transection of the
proximal margin (7%). Overall morbidity rates were 17%. The anastomotic leak rate was
1.4% (n ¼ 2). There were no anastomotic leaks in the 11 patients who had a change in
surgical plan based on intraoperative perfusion assessment with FA.
CONCLUSIONS: PINPOINT is a safe and feasible tool for intraoperative assessment of tissue perfusion during
colorectal resection. There were no anastomotic leaks in patients in whom the anastomosis
was revised based on inadequate perfusion with FA. (J Am Coll Surg 2015;220:82e92.
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Figure 1. PINPOINT Endoscopic Fluorescence Imaging System
(Novadaq). (Reprinted from Novadaq Technologies Inc, with
permission.)
Abbreviations and Acronyms
FA ¼ fluorescence angiography
ICG ¼ indocyanine green
IMA ¼ inferior mesenteric artery
NIR ¼ near infrared
VIS ¼ visible
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in surgical technique, technology, and neoadjuvant treat-
ments currently allow surgeons to create lower anastomo-
ses as an alternative to permanent colostomies.1-3
However, anastomotic leak after colorectal resection in-
creases morbidity, mortality, and, in patients with rectal
cancer, local recurrence rates.4,5 The reported rate of anas-
tomotic leak after colorectal surgery ranges from 3% to
20%.6-9 However, recent large randomized controlled
trials10 and cohort comparison studies11 have shown leak
rates after rectal anastomosis of 11% to 15%. Morbidity
related to an anastomotic leak can be substantial, with
an increased associated mortality of 6% to 22%.9,12
Anastomotic leak can be attributed to patient risk fac-
tors, technical factors, and blood supply of the distal
and/or proximal segments of bowel. Literature has identi-
fied male sex, level of anastomosis, tobacco use, preoper-
ative radiation, and the presence of adverse intraoperative
events as markers of high-risk anastomoses.3,5,13-15 Howev-
er, perfusion abnormalities and anastomotic technique are
the 2 most commonly invoked factors having significant
impact on the healing of an anastomosis.4,16-19
We hypothesized that assessment of microperfusion at the
time of the creation of an anastomosis may influence the rate
of anastomotic leak. Therefore, a technology that would
accurately predict perfusion may potentially improve out-
comes. Fluorescence angiography has been shown to be an
accurate tool for assessing microperfusion and has been asso-
ciated with improved outcomes in hepatobiliary, foregut,
transplant, and plastic surgery.20-26 Therefore, we proposed
amulticenter, open label clinical trial to demonstrate the util-
ity and feasibility of intraoperative perfusion assessment us-
ing near infrared (NIR) indocyanine green (ICG)-induced
fluorescence angiography at the time of anastomosis creation.
METHODS
This was a multicenter prospective, open label clinical trial.
Participating institutions were Beth Israel Medical Center,
New York, NY; Cleveland Clinic Florida, Weston, FL;
Maimonides Medical Center, Brooklyn, NY; Mayo Clinic,
Rochester, MN; New York Presbyterian Hospital, Weill
Cornell Medical Center, New York, NY; Ochsner Clinic
Foundation, New Orleans, LA; Surgical Disciplines,Central Michigan University, College of Medicine, Sagi-
naw, MI; University of California, Irvine Medical Center,
Orange, CA; University of California San Diego Medical
Center, La Jolla, CA; University of California San Fran-
cisco Medical Center, San Francisco, CA; University
Hospitals-Case Medical Center, Cleveland, OH. A total
of 26 surgeons participated in the trial.
Figure 2. Proximal colonic point of transection was marked by a surgical clip under white/visible
light. (Reprinted from Novadaq Technologies Inc, with permission.)
84 Jafari et al Perfusion Assessment in Low Anterior Resection J Am Coll SurgThe study was conducted in accordance with the
ethical principles of the Declaration of Helsinki (Edin-
burgh 2000), and Institutional Review Board approval
was obtained by all institutions. Informed consent was
obtained for all subjects. Patients were eligible for enroll-
ment if they were over 18 years old and were scheduled
for a laparoscopic left colectomy or anterior resection
with a planned anastomosis located 5 to 15 cm from
the anal verge. Patients with a history of adverse reaction
or known allergy to ICG, iodine, or iodine dyes were
not eligible. Pregnant and/or lactating patients were
excluded.Figure 3. Perfusion of the planned transection p
raphy. The line of demarcation between perfus
compared with the initial planned transection poin
perfused tissue. White arrow points to the line
nonperfused bowel. (Reprinted from Novadaq TecSubjects received a baseline assessment. Demographics
including age, sex, ethnicity or race, body mass index,
American Society of Anesthesiologist class, preoperative
diagnosis, history of preoperative chemotherapy (<90
days from day of operation) and radiotherapy, history
of smoking or alcohol use, and complete medical history
were collected.
During the surgical procedure, the PINPOINT Endo-
scopic Fluorescence Imaging System (Novadaq) (Fig. 1)
was used to assess perfusion of colonic tissue at 2 critical
steps of the operation: the planned point of proximal
transection just before bowel resection and completionoint was visualized via fluorescence angiog-
ed and nonperfused tissue was noted and
t. The bowel was transected at an area of well-
of demarcation between well-perfused and
hnologies Inc, with permission.)
Figure 4. Fluorescence angiography of the completed anastomosis. (Reprinted from of Novadaq
Technologies Inc, with permission.)
Vol. 220, No. 1, January 2015 Jafari et al Perfusion Assessment in Low Anterior Resection 85of the anastomosis (“baseline image”), and after comple-
tion of the anastomosis, when the integrity of the mucosal
aspect of the completed anastomosis was assessed via proc-
toscopy. The protocol allowed for the surgical technique
to otherwise be performed according to each surgeon’s
standard practice, including the surgeon’s standard prac-
tice for assessing perfusion. The surgical plan (site of
resection or anastomoses and plan for diversion) was
documented before fluorescence angiography. Operative
factors included planned surgical procedure, ostomy
diversion plan and use, type and level of anastomosis,
operative time, level of inferior mesenteric artery (IMA)
ligation, splenic flexure mobilization, number of linear
staple firings used to transect the proximal and distal
bowel, and use of a pelvic drain, and all were recorded.
Any revisions to the surgical plan were documented. All
of the techniques mentioned above were left to the discre-
tion of the attending surgeon. Ligation of the inferior
mesenteric artery proximal to the left colic vessels was
labeled as “high,” just distal to the left colic vessels as
“mid,” and at the level of the colon marginal vessels as
“low.” Anastomotic height was measured and was consid-
ered “low-risk” if located 10 to 15 cm and “high-risk” if
located 5 to 10 cm from the dentate line. High-risk anas-
tomosis also included patients with a history of pelvic
radiation.
For the initial “baseline image” assessment, the planned
point of proximal colon transection was marked by the sur-
geon, typically with a clip or by marking via an instrument,
under white or visible light before imaging with PINPOINT
(Fig. 2). This perfusion was performed after mobilization of
the bowel, transection of the rectum, division of the rectal
and colon mesentery and central vessels, before specimenextraction or resection and creation of the anastomosis.
This site was selected by the surgeon using his or her best
judgment and typical standard of care assessment. After
this selection, the anesthesiologist administered a bolus of
3.75 to 7.5 mg ICG intravenously. Perfusion of the colon
was visualized and assessed via fluorescence angiography
and the line of demarcation between perfused and nonper-
fused tissue was noted and compared with the initial planned
transection point (Fig. 3). The colon was then divided
within an area of well-perfused tissue (Video 1, online).
Perfusion of the planned transection margin was assessed
as inadequate, adequate, or optimal, and the impact of the
perfusion assessment with fluorescence angiography was
documented as “change” or “no change” to the resection
margin. When a case required conversion to open, the lapa-
roscope could be used to image the segment of bowel extra-
corporeally. Whether patients were imaged after conversion
was left to the discretion of the surgeon. All converted cases
that were not imaged were excluded from final analysis. All
robotic cases were hybrid in nature and PINPOINT was
used during the laparoscopic portion of the case.
After completion of the anastomosis (end-to-side or
end-to-end, according to surgeon preference and standard
practice), a standard air leak test was performed. Any leaks
were documented and managed according to each indi-
vidual surgeon’s standard of care. After the air leak test,
perfusion of the completed anastomosis was assessed
with fluorescence angiography. The PINPOINT endo-
scope was inserted into the anus using a disposable intro-
ducer and advanced to the staple line of the anastomosis
under visible or white light guidance. A second bolus of
3.75 to 7.5 mg of ICG was administered intravenously.
Real-time perfusion of both proximal and distal aspects
Table 1. Demographic Characteristics of Patients
Who Underwent Fluorescence Angiography During Left
Colectomy/Low Anterior Resection (n ¼ 139)
Characteristic Data
Age, y, mean  SD 58  14
Sex, n (%)
Female 65 (46.8)
Male 74 (53.2)
Race, n (%)
Asian 14 (10.0)
Black or African American 7 (5.0)
Hispanic 10 (7.2)
Middle Eastern 2 (1.4)
White 106 (76.3)
Hispanic 3 (2.2)
Body mass index (BMI), kg/m2, mean  SD 29  6
BMI > 30, n (%) 42 (30.2)
BMI  30, n (%) 97 (69.8)
American Society of Anesthesiologists, n (%)
I 17 (12.2)
II 73 (52.5)
III 46 (33.1)
IV 3 (2.2)
Diagnosis, n (%)
Diverticulitis 61 (43.9)
Rectal cancer 35 (25.2)
Colon cancer 29 (20.9)
Polyp 6 (4.3)
Procidentia 4 (2.9)
Crohn’s disease 1 (0.7)
Colovesical fistula 1 (0.7)
Radiation stricture 1 (0.7)
Sigmoid volvulus 1 (0.7)
Preoperative chemotherapy, n (%) 13 (9.4)
Preoperative radiation therapy, n (%) 15 (10.8)
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or optimal, and any change to the surgical plan based
on fluorescence angiography of the anastomosis was docu-
mented (Fig. 4). These included any revision to the anas-
tomosis, and/or a change in the decision to perform a
protective ostomy.
The primary end points were the feasibility and safety of
fluorescence angiography during low anterior resection and
left colectomy. The incidence of use of fluorescence angiog-
raphy to aid in surgical decision-making was measured.
The number of cases in which the planned location of
resection margin of the colon or rectum and/or revision
of the anastomosis changed due to perfusion assessment
was recorded. Any change in decision to divert was also
recorded. The incidence of successful imaging and assess-
ment of perfusion of the planned resection margins based
on the ability to obtain images that allowed adequate perfu-
sion assessment, and the incidence of successful imaging
and assessment of the completed anastomosis based on
the ability to obtain images that allowed for adequate
perfusion assessment were also evaluated.
Secondary endpoints included clinical outcomes of
the procedures performed. The incidence of major post-
operative clinical complications with a minimum 30-day
postprocedure follow-up was collected. Major postoper-
ative clinical complications included clinically evident
anastomotic leak, radiologic anastomotic leak (when
prompted by clinical suspicion), and postoperative fever
and delay in return of bowel function. Clinical suspicion
and surgeon standard of practice were used as guideline
for assessment of an anastomotic leak. The appropriate
modality for assessment of anastomotic leak was also
left to the discretion of the surgeon. The incidence of
all other operative complications was summarized based
on relationship, seriousness, and severity. A complica-
tion was listed as mild if it was transient or easily toler-
ated, moderate if it caused discomfort or interfered with
general condition, and severe if it caused considerable
interference with general condition. The length of stay
in the hospital and number of ICU days were also
included as secondary endpoints. Postoperative recovery
was at the discretion of the surgeon because no pathway
was required. Thirty-day follow-up of all subjects was
conducted, at which time all postoperative morbidity
was captured and recorded.
PINPOINT Endoscopic Fluorescence Imaging
System
The PINPOINT Endoscopic Fluorescence Imaging Sys-
tem is manufactured by Novadaq Technologies Inc. The
system enables the surgeon to assess perfusion with real-
time endoscopic high definition visible (VIS) and NIRfluorescence imaging. The PINPOINT system includes a
surgical laparoscope optimized for VIS/NIR illumination
and imaging, a camera head that is also optimized for
VIS/NIR imaging and mounts to the laparoscope eyepiece,
and an endoscopic video processor/illuminator capable of
providing VIS/NIR illumination to the surgical laparo-
scope via a flexible light guide cable and the image process-
ing required to generate simultaneous, real-time high
definition video color (VIS) and NIR fluorescence images.
PINPOINT is designed to be connected to a medical
grade-high definition color video monitor and all compo-
nents may be mounted on a stand-alone endoscopy tower.
The PINPOINT system allows simultaneous display
of multiple images, including standard high definition
white light imaging. Real time NIR fluorescence video
Table 2. Comorbidities of Patients Who Underwent Fluo-
rescence Angiography During Left Colectomy/Low Anterior
Resection (n ¼ 139)
Comorbidity n %
Cardiovascular 61 43.9
Endocrine 33 23.7
Hematologic/lymphatic 8 5.8
Metabolic/nutritional 36 25.9
Musculoskeletal 31 22.3
Nervous/psychiatric 23 16.5
Respiratory 10 7.2
Skin 14 10.1
Ear, nose and throat 21 15.1
Urogenital 55 39.6
Current smoker 18 12.9
Former smoker 30 21.6
Alcohol weekly 52 37.4
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may be viewed in 2 ways: PINPOINT image, in which
NIR fluorescence is superimposed in pseudo-color (green)
on a white light image; and SPY image, in which a
black and white NIR fluorescence image is displayed
(Figs. 2 and 3). The PINPOINT system can include
various components and software upgrades with a list
price of $167,500 to $223,750 and a cost per case of
$999 to $1,099.Table 3. Description of Operative Technique and Findings Dur
Operative technique and finding
Laparoscopic left colectomy/anterior resection, n (%)
Robotic left colectomy/anterior resection, n (%)
Converted to an open procedure, n (%)
Splenic flexure mobilization, n (%)
Level vessel ligation, n (%)
High ligation of IMA (proximal to left colic takeoff)
Low ligation of IMA
Mid ligation IMA (distal to left colic takeoff)
IMA not ligated
Ileostomy, n (%)
Level of anastomosis, cm, mean  SD (range)
<8, n (%)
8e9, n (%)
10, n (%)
Baseline PINPOINT image acquired, n (%)
Change to resection margin, n (%)
Distance from planned transection, cm, mean  SD (range)
PINPOINT alters surgical plan after creation of anastomosis, n (%)
Revision of anastomosis
Confirmation of vascular supply to anastomosis
Operative time, h, mean  SD (range)Indocyanine green
Indocyanine green (ICG) is approved for human use by
the United States Food and Drug Administration
(FDA). It is a sterile, water-soluble, tricarbocyanine com-
pound that can be administered intravenously or intra-
arterially. It absorbs NIR light at 800 nm, and emits
fluorescence (light) at a slightly longer wavelength of
830 nm. Indocyanine green rapidly and extensively binds
to plasma proteins and is confined to the intravascular
compartment, with minimal leakage into the interstitium.
It is cleared by the liver in 3 to 5 minutes into bile with no
known metabolites. Indocyanine green contains no more
than 5.0% sodium iodide and should be used with caution
in patients who have a history of allergy to iodides or iodin-
ated imaging agent. The most serious, but rare, risk of ICG
when administered intravenously in humans, according to
the IC-GREEN (Akorn) product label, is anaphylactic
death, which has been reported after IC-GREEN adminis-
tration during cardiac catheterization.27-29RESULTS
A total of 147 patients were enrolled between July 2012
and July 2013 at 11 institutions in the United States, of
whom 139 were eligible for final analysis. Ineligibility
was secondary to planned anastomosis < 5 cm, no anas-
tomosis, and/or ileorectal anastomosis, as listed ining Utilization of Fluorescence Angiography (n ¼ 139)
Data
120 (86.3)
19 (13.7)
5 (3.6)
112 (80.6)
86 (61.9)
19 (13.7)
33 (23.7)
1 (0.7)
26 (18.7)
10.4  3.9 (5e15)
36 (25.9)
16 (11.5)
87 (62.6)
137 (98.6)
9 (6.5)
3.6  4 (0.5e14)
2
1 (0.7)
1 (0.7)
4  1.4 (1e10)
Table 5. Secondary Endpoints at 30-Day Follow-up of
Patients Who Underwent Fluorescence Angiography During
Left Colectomy/Low Anterior Resection (n ¼ 139)
Endpoint n %
Clinical anastomotic leak (day 30)* 2 1.4
Anastomotic leak confirmed by radiology (day 30)* 2 1.4
Postoperative fever (day 30) 7 5.0
Delay in return of bowel function (day 30) 5 3.6
*The 2 patients with anastomotic leak were discovered via clinical findings
and confirmed via radiologic imaging.
Table 4. Postoperative Morbidity of Patients Who Under-
went Fluorescence Angiography During Left Colectomy/Low
Anterior Resection (n ¼ 139)
Morbidity n %
Postoperative morbidity 23 16.5
Anastomotic leak 2 1.4
Pelvic abscess 2 1.4
Abdominal wall infection 1 0.7
Acute renal failure 1 0.7
Blood transfusion 1 0.7
C. difficile colitis 1 0.7
Fever 1 0.7
Ileus 1 0.7
Ileus requiring nasogastric tube 1 0.7
Small bowel obstruction 1 0.7
Incisional hernia 1 0.7
Thrombosed left renal artery 1 0.7
Urinary retention 1 0.7
Urinary tract infection 1 0.7
Wound infection 1 0.7
Other 6 4.3
Morbidity related to
Surgical procedure 17 12.2
Comorbid condition 1 0.7
Other 5 3.6
Severity of complication 0.0
Mild 14 10.1
Moderate 7 5.0
Severe 2 1.4
Return to operating room 0 0.0
Length of stay (mean  SD [range]) was 6  3 days (1e25 days).
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(SD) was 58 14 years, and 53% of patients were
male. Obesity (BMI >30 kg/m2) was prevalent in 30%,
and the majority of patients were American Society of An-
esthesiologists (ASA) II (53%). Diverticulitis (44%),
rectal cancer (25%), and colon cancer (21%) were the
most prevalent preoperative diagnoses. Of the patients
with rectal cancer (n ¼ 35), 43% underwent preoperative
pelvic radiation (Table 1). Cardiovascular disease (44%),
and urogenital disease (40%) were the most prevalent
comorbidities (Table 2).
Laparoscopic resection was used in 86% and robotic
surgery in 14% of the patients imaged. There was an over-
all conversion rate of 7.8% (n ¼ 12); 5 of these patients
were imaged, and 7 patients were not included due to a
decision not to image. The splenic flexure was mobilized
in 81% of patients, and a high ligation of the IMA was
performed in 61.9% of cases. Successful imaging was ob-
tained in 98.6% of cases in which perfusion imaging was
attempted. Imaging was unsuccessful in 2 patientssecondary to equipment malfunction. Fluorescence angi-
ography imaging changed the surgical plan in 11
(7.9%) patients. This included revision of the point of
proximal colon transection (Video 1), as indicated by
perfusion assessment in 9 patients (6.5%); takedown
and revision of the completed anastomosis after transanal
perfusion assessment in 1 patient; and confirmation of
viability of anastomosis with concerns of malperfusion
based on traditional methods of assessing viability of the
anastomosis under white light in 1 patient. The use of
transanal fluorescence angiography with findings of
adequate perfusion altered the intraoperative plan for
diversion to no diversion in this patient. There were no
anastomotic leaks in the 11 patients in whom a change
in the surgical plan occurred based on fluorescence angi-
ography findings (Table 3). The rate of splenic flexure
mobilization was similar in patients with change in surgi-
cal plan (82%) and those who did not require revision
(81%). There were no reported cases in which change
in surgical plan was based on standard assessment of
bowel before the use of fluorescence angiography.
Postoperative complications were observed in 17% of
patients; 12% of these were secondary to the surgical pro-
cedure and 2 (1.4%) were severe in nature (Table 4). The
2 abscesses reported were not associated with an anasto-
motic leak. The first case was a recurrent abscess in a pa-
tient with a colovesicular fistula, in whom an abscess
adjacent to the bladder was discovered at the index oper-
ation. In the second case, the abscess was proven to have
no communication with the anastomosis, as evidenced by
lack of contrast extravasation on imaging and a lack of air
within the abscess cavity. Therefore, this abscess was
deemed not related to an anastomotic leak. These 2 pa-
tients with abscesses were treated with only antibiotics
and had complete resolution, with no other intervention.
There were 2 patients who received postoperative antibi-
otics beyond the 24-hour postoperative period; both pa-
tients were treated for abscess or phlegmon found
during the index operation for diverticular disease, and
antibiotics were discontinued by postoperative day 4.
All recorded fevers had an attributable source as listed
Table 6. Postoperative Morbidity for High-Risk (Anastomosis < 10 and/or Pelvic Radiation) Compared with Low-Risk
Anastomosis of Patients Who Underwent Fluorescence Angiography During Left Colectomy/Low Anterior Resection
Morbidity Low-risk anastomosis (n ¼ 86) High-risk anastomosis (n ¼ 53)
PINPOINT image acquired, % 98.8 98.1
Impact on surgical plan, % 5.8 7.5
PINPOINT altered surgical plan after anastomosis, % 1.2 1.9
Revision of anastomosis 0.0 1.9
Confirmation of vascular supply to anastomosis 1.2 0.0
Postoperative morbidity, % 16.3 17.0
Morbidity related to, %
Surgical procedure 12.8 11.3
Comorbid condition 0.0 1.9
Other 3.5 3.8
Severity of complication, % 0.0 0.0
Mild 12.8 5.7
Moderate 1.2 11.3
Severe 2.3 0.0
In-hospital postoperative complications, %
Anastomotic leak 1.2 1.9
Pelvic abscess 1.2 1.9
Abdominal wall infection 1.2 0.0
Acute renal failure 1.2 0.0
Blood transfusion 0.0 1.9
C. difficile colitis 1.2 1.9
Fever 1.2 0.0
Ileus 0.0 1.9
Ileus requiring nasogastric tube 0.0 1.9
Small bowel obstruction 0.0 1.9
Incisional hernia 1.2 0.0
Thrombosed left renal artery 1.2 0.0
Urinary retention 1.2 0.0
Urinary tract infection 0.0 1.9
Wound infection 0.0 1.9
Other 5.8 1.9
30-d outcomes, %
Clinical anastomotic leak 1.2 1.9
Anastomotic leak confirmed by radiology* 1.2 1.9
Postoperative fever 2.3 9.4
Delay in return of bowel function 1.2 7.5
*The 2 patients with anastomotic leak were discovered via clinical findings and confirmed via radiologic imaging.
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tion, and/or Clostridium difficile infection.
Two (1.4%) anastomotic leaks were clinically suspected
and radiologically confirmed (Table 5). Both patients had
undergone low ligation of the IMA with an end-to-end
anastomosis without diversion. One patient had rectal
cancer with no history of preoperative chemotherapy or
radiation and underwent a 6-hour laparoscopic anterior
resection with splenic flexure mobilization with anasto-
mosis at 6 cm. A defect of the anastomosis wasdemonstrated on CT scan, which was obtained due to
clinical suspicion on postoperative day 12. The patient
was treated with a readmission, antibiotics, and transglu-
teal percutaneous drainage without diversion. The second
patient had a diagnosis of diverticulitis and underwent a
3-hour laparoscopic anterior resection with anastomosis
at 11 cm. A CT scan performed on postoperative day
12 due to clinical suspicion of a leak showed a small ab-
scess containing air adjacent to the anastomosis. The pa-
tient was treated with readmission and antibiotics. Both
90 Jafari et al Perfusion Assessment in Low Anterior Resection J Am Coll Surgpatients had complete resolution of symptoms without
any further treatment. Table 6 lists outcomes with regard
to high-risk (anastomosis < 10 cm and/or pelvic radia-
tion) vs low-risk (10 cm and no radiation) patient
populations.DISCUSSION
Anastomotic leak is a significant complication of colo-
rectal resection and leads to increased length of stay,
cost, local recurrence, and mortality rates.4,5 Factors lead-
ing to anastomotic leak include patient characteristics,
anastomotic integrity, and viability. Perfusion and tissue
viability remain an area in which improvement may be
achieved with the introduction of new technology. The
ability to assess intraoperative perfusion accurately via
easy to use and accessible methods is, therefore, of poten-
tial importance. This clinical trial demonstrated that
PINPOINT is feasible and safe with no reported adverse
events. Successful imaging was obtained in 98.6% of
cases. Perfusion imaging led to a change in surgical plan
in 7.9% of patients; all of these patients were discharged
without any reported severe complications. The anasto-
motic leak rate (1.4%) in this trial was lower than the re-
ported rates in multiple recent large prospective
randomized and cohort comparison studies in the litera-
ture (3% to 15%).7,8,10,11
The primary objective was to demonstrate the safety and
feasibility of the intraoperative assessment of colon and
rectal perfusion using fluorescence angiography during
left colectomies and low anterior resections. This technol-
ogy was easy to implement because the device is similar
to a standard laparoscope, with a minimal learning curve
for application and use. This technology was used by 11 in-
stitutions according to surgeon preference, and there were
no reported difficulties in assessment despite the absence
of any “run in” or practice cases. No complications attrib-
utable to the use of the ICG or the device were observed.
Successful imaging demonstrated no apparent limitation
with regard to imaging converted cases. There were no re-
ported limitations to imaging and/or interpretation with
regard to patient comorbidities. Fluorescence angiography
has been found to be beneficial in assessing perfusion in
earlier reports, aiding in surgical decision making and
improving outcomes in cardiothoracic, hepatobiliary, colo-
rectal, foregut, transplant, and plastic surgery.1,5,20-26 The
feasibility and applicability of this new technology with
the implications of potentially reducing anastomotic leak
rates could make it an invaluable tool for use in high-risk
colorectal resections.28
Our results indicate that assessment of microperfusion
of the transected bowel and planned site of anastomosiswas associated with revision of surgical plan in nearly
8% of patients. To our knowledge, there are only 2
studies in the literature that have demonstrated the bene-
fits of angiography in colorectal surgery.1,5 Kudszus and
colleagues5 reported a 14% (n ¼ 201) change in resection
margin using laser fluorescence angiography. These find-
ings were confirmed by Jafari and colleagues1 using Firefly
(Intuitive Surgical Inc). The authors demonstrated a 19%
change in transection point using fluorescence angiog-
raphy compared with 4.5% using visible or white light
during robotic low anterior resections. Our data confirm
earlier reports that conventional methods of assessing
bowel perfusion are not entirely reliable.1,5,30 To date, sub-
jective methods such as active bleeding, palpable pulsation
in the mesentery, and bowel discoloration, have been
used. These methods are not objective and can be lacking
in a laparoscopic colon resection secondary to the lack of
tactile sensation and change in visual cues. In the majority
of laparoscopic colectomies, as opposed to open tech-
nique, the bowel is transected and reanastomosed shortly
after transection of the mesentery, thereby limiting obser-
vation time. Conventional techniques of assessing perfu-
sion may not be entirely applicable with laparoscopy
and even with laparotomy are not objective. Our data sug-
gest that conventional assessment may have a failure rate
that contributes to anastomotic leak. Although laser
Doppler flowmetry and laser fluorescence angiography
are earlier described reliable methods of measuring intra-
operative perfusion,17-19,24,31,32 they can be cumbersome
and difficult to implement, especially during laparoscopic
operations.
The use of fluorescence angiography has potential for
great clinical significance on outcomes of colorectal sur-
gery especially with regard to high-risk anastomoses.
Our data are consistent with this hypothesis by demon-
strating lower anastomotic leak rates than those reported
in the literature, even within the high-risk group. This
result concurs with earlier reports by both Kudszus and
colleagues5 and Jafari and colleagues,1 which demon-
strated decreases in leak rates of 60% and 66%, respec-
tively, when compared with a control group. Jafari and
colleagues1 included a high-risk population of rectal can-
cer patients undergoing low anterior resection with anas-
tomoses at a mean level of <5.5 cm from the anal verge.
There was a reported 63% rate of history of radiation use
in the fluorescence group. We demonstrated an anasto-
motic leak rate of 1.4% (n ¼ 2), which is a promising
reduction compared with that reported in the literature
(12%).7,8 Considering the incidence of changes in the
resection margin/anastomosis (n ¼ 10) as high-risk pa-
tients who may have had leaks due to relative ischemia,
it is intriguing to note that if half of these patients had
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all of these patients had leaks, the rate would have been
8.6%, putting the leak rate into an expected range for a
heterogeneous group of medium- and high-risk patients.
Adequate perfusion is a key component of anastomotic
integrity. To date, conventional methods have been inad-
equate, as demonstrated by a high rate of anastomotic fail-
ures, and almost mandatory use of diverting ileostomy for
low pelvic, high risk anastomoses. These anastomotic
leaks have a substantial impact on the morbidity and mor-
tality of patients.2,3,13,27,30,33,34 Therefore, any method to
decrease the rate of anastomotic leak is of significant inter-
est. Although patient-related-factors cannot be easily
altered, there is potential to improve the assessment of
bowel perfusion, viability, and anastomotic integrity.
Our data may support the use of fluorescence angiography
to allow for visualization of microperfusion of the bowel,
which may, in turn, improve outcomes and decrease
morbidity rates associated with anastomotic leaks. The 2
patients who developed anastomotic leaks in our series
had minimal morbidity and required minimal interven-
tions to manage the leak.
This study should be viewed with certain significant
limitations. As a prospective single armed study of mod-
erate size, inherent biases exist. There was no standardiza-
tion with regard to technique of operation and
anastomosis or preoperative or postoperative care.
Although total operative time was recorded, the total im-
aging time was not recorded. Importantly, there was no
standardization of the “standard of care” assessment of
proximal bowel viability based on normal visual assess-
ment or assessment of bleeding at the transection line.
The patients were a heterogeneous group undergoing
low pelvic and relatively high-risk anastomoses. This het-
erogeneous population and our sample size did not allow
us to draw any specific conclusions with regard to the
consequence that patient characteristics may have on
interpretation of data. However, we report a 98.6% suc-
cessful imaging rate and did not encounter any difficulty
in interpreting fluorescence angiography in patients with
peripheral vascular disease (n ¼ 3), and/or diabetes
(n ¼ 11). The low conversion rates may imply a more
experienced and skilled set of surgeons as compared
with those reported in the literature, which may translate
into a lower morbidity.7,35
Despite the modest variability in practice, surgical pref-
erence, and technique, we have demonstrated that this
technology for assessing anastomotic perfusion is reliable,
safe, easy to use, and may lower the rate of anastomotic
leaks in patients undergoing colorectal surgery. Although
many factors that contribute to failure of an anastomosis
are out of a surgeon’s control, this technology offers a newand seemingly reliable technique to lend credence to the
surgical dogma that blood supply and viability have a
large impact on the creation of a healthy anastomosis.
CONCLUSIONS
In conclusion, this study demonstrates the feasibility and
safety of fluorescence angiography using PINPOINT dur-
ing left segmental colectomy and anterior resection. The
study further demonstrates that the use of this technology
may result in revisions of the proximal planned bowel
transection point, and provide florescence angiography
perfusion assessment of a completed anastomosis. Intrao-
perative assessment of perfusion of the bowel planned for
primary anastomosis with florescence angiography may
decrease the rates of anastomotic leak and thereby
improve patient outcomes. A randomized controlled clin-
ical trial is planned to further evaluate the true clinical sig-
nificance of this new technology compared with the more
standard assessment of the proximal transection line.
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Appendix 1. Patients Excluded from Final Analysis
Reason for exclusion Anastomotic leak
Anastomosis < 5 cm from the anal verge* Yes
The tumor was at the splenic flexure. Anastomosis at 25 cm* No
Ileo-colonic anastomosis at 20 cm* No
Laparoscopic total abdominal colectomy with ileo-rectal anastomosis* No
Laparoscopic total abdominal colectomy with ileo-rectal anastomosis* No
Total proctocolectomy with ileo-anal anastomosis with j-pouch* No
No anastomosis due to intraoperative pathology findings N/A
Abdominoperineal resection (no anastomosis) N/A
*Fluorescence angiography was performed.
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